bioRxivImmunologyPreprint
Deciphering the mystery of influenza virus A antigenic drift and immune escape
Abstract
The biggest challenge of influenza A virus vaccine development is the constant mutation of the virus, especially the antigenic drift. Therefore, we suggest establishing a research system for upgrading of current influenza A vaccines. The most fundamental but neglected thing is to determine the immune escape mutation (IEM) map (IEMM) of 20 amino acids in linear epitope to reveal the precise mechanism of the viral immune escape. Based on this assumption, we primarily divided IEM of HA-tag linear epitope into four types according to antibody affinity by ELISA. Our aim is to attract scholars to establish of IEMM library to deal with influenza A virus mutations in the future.
- organism: virus
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antigenic drift expands viral escape pathways from imprinted host humoral immunity
D. P. Maurer, M. Vu, A. G. Schmidt·bioRxiv·Mar 20, 2024
- Deciphering the rule of antigen-antibody amino acid interaction
M. Jiang, C. Fang, Y. MA·Frontiers in ImmunologyPeer-reviewed·Dec 4, 2023
- Sera from individuals with narrowly focused influenza virus antibodies rapidly select viral escape mutations in ovo
A. K. F. Davis, K. McCormick, … S. E. Hensley·bioRxiv·May 17, 2018
- Characteristics of epitopes of limited variability on the head of influenza H1 haemagglutinin
José Lourenço, Hany S. Zinad, … Sunetra Gupta·bioRxiv·Apr 30, 2024
- Novel epitopes of human monoclonal antibodies targeting the influenza virus N1 neuraminidase
E. Kirkpatrick Roubidoux, M. McMahon, … F. Krammer·bioRxiv·Feb 26, 2021
- Role of the amino acid mutations in the HA gene of H9N2 avian influenza virus under selective pressure in escape vaccine antibodies